Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 31Lymphoma, Non-Hodgkin 20Lymphoma, Follicular 20Lymphoma 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, B-Cell 11Neoplasms 10Recurrence 8Lymphoma, Mantle-Cell 7Lymphoma, T-Cell, Peripheral 6Leukemia 5Hematologic Diseases 5Sarcoma, Kaposi 3Neuroblastoma 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3HIV Infections 3Acquired Immunodeficiency Syndrome 3Wilms Tumor 2Small Cell Lung Carcinoma 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphatic Diseases 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Burkitt Lymphoma 2Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1

Interventions

Injections 24pembrolizumab 13toripalimab 12tislelizumab 9Gemcitabine 7Cisplatin 7Carboplatin 6atezolizumab 5Nivolumab 5Irinotecan 5Pemetrexed 4Oxaliplatin 4Leucovorin 4Fluorouracil 4Docetaxel 4Cetuximab 4trastuzumab deruxtecan 3spartalizumab 3cediranib 3Paclitaxel 3PM 01183 3Capecitabine 3sintilimab 2olaparib 2lenvatinib 2glumetinib 2camrelizumab 2apatinib 2Therapeutics 2Midazolam 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Solid Tumor × Vincristine × Clear all
NCT05279300 2025-08-11

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

CStone Pharmaceuticals

Phase 1 Recruiting
480 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡